Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

18 Sep 2013 07:00

RNS Number : 2114O
Standard Life Euro Pri Eqty Tst PLC
18 September 2013
 



 

 

 

 Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2013

 

· NAV rose by 1.4% to 247.3p for the quarter ended 30 June 2013

· NAV total return was up 8.1% for the six months starting 1 January 2013

· Realised gains and income during the quarter ended 30 June 2013 were £7.1 million (1.8% of NAV). The unrealised losses on the portfolio on a constant exchange rate basis were £4.8 million (1.2% of NAV); in addition, there were unrealised foreign exchange gains of £4.2 million (1.1% of NAV).

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2013

· Outstanding commitments were £197.4 million at 30 June 2013

· Net cash was £27.7 million at 30 June 2013

 

For the quarter ended 30 June 2013 the Company's net asset value per ordinary share ("NAV") rose by 1.4% to 247.3p (diluted - 244.2p), from 243.9p (diluted - 240.9p) at 31 March 2013. At 30 June 2013 the Company's net assets were £400.0 million (31 March 2013 - £394.5 million).

 

The volume of new transactional activity remained subdued in the European private equity market in the second quarter of 2013, due to the challenging macro-economic and political environment in Europe. However, supported by increased liquidity in the leveraged debt markets the value of new transactions rose markedly, with a notable rise in the number of large and mega buy-outs. A total of €26.5 billion of transactions by enterprise value was reported during the quarter, which was materially higher than the €10.4 billion reported in the first quarter of 2013. The Manager also continued to see exit activity across the Company's portfolio as private equity managers focused on selling, or in some instances re-capitalising, investee companies.

 

The closing value of the Company's portfolio of 41 private equity fund interests was £374.3 million at 30 June 2013 (31 March 2013 - £375.7 million). The total unrealised losses on the portfolio for the quarter ended 30 June 2013 were £0.6 million, of which £4.8 million were unrealised losses on a constant exchange rate basis and £4.2 million were unrealised foreign exchange gains. The £4.8 million of losses in the value of the portfolio on a constant exchange rate basis reflected weaker listed equity markets, partially offset by positive earnings growth at many underlying portfolio companies. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 3.2% and 2.7% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 1.3% relative to sterling over the quarter.

 

During the quarter the Company funded £7.5 million of draw downs (six months ended 31 March 2013 - £21.1 million) and received £15.5 million of distributions (six months ended 31 March 2013 - £28.5 million). The distributions received generated £7.1 million of realised gains and income, which was equivalent to a return of 1.9 times the acquisition cost of the realised investments.

 

On 28 June 2013 the Company made a new primary fund commitment of €30.0 million to CVC Capital Partners VI. The Company has invested in five prior funds of the manager, CVC Capital Partners.

 

The Company had total outstanding commitments of £197.4 million at 30 June 2013 (31 March 2013 - £177.3 million). At 30 June 2013 the Company had a cash balance of £27.7 million (31 March 2013 - £21.5 million).

 

 

2. Activity since 30 June 2013

 

During the period from 30 June 2013 to 17 September 2013 the Company funded £9.4 million of draw downs and received £13.9 million of distributions. The Company made no new primary fund commitments during the period, however, the Company completed the purchase of an original commitment of €10 million to Bridgepoint Europe IV in July 2013. The fund interest was acquired at a 4% discount to the 31 December 2012 valuation of the fund, adjusted for subsequent cashflows. The purchase price for the fund interest was £7.4 million and the Company assumed £1.6 million of outstanding commitments.

 

In addition, the Company completed the sale of its remaining original commitment of €30 million to Charterhouse VIII in August 2013. The fund interest was sold at a 2% discount to the 31 March 2013 valuation of the fund, adjusted for subsequent cashflows. The sale price for the interest was £18.5 million and the Company was released from £3.4 million of outstanding commitments.

 

Accordingly, at 17 September 2013 the Company's total outstanding commitments and cash balance were £181.6 million and £40.5 million respectively.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2013 on or around 28 November 2013.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXDLFFXKFBBBE
Date   Source Headline
7th Dec 20124:53 pmRNSTransaction in Own Shares
3rd Dec 20127:00 amRNSPreliminary Results
1st Oct 201210:48 amRNSQuarterly Disclosure
19th Sep 20127:00 amRNSQuarterly Trading Statement
17th Aug 201210:57 amRNSInterim Management Statement
9th Jul 20125:04 pmRNSHolding(s) in Company
9th Jul 201211:44 amRNSHolding(s) in Company
2nd Jul 20122:39 pmRNSQuarterly Disclosure
1st Jun 20124:56 pmRNSDirector/PDMR Shareholding
29th May 20125:28 pmRNSHalf Yearly Report
24th May 20129:10 amRNSDirector Declaration
2nd Apr 201212:43 pmRNSQuarterly Disclosure
21st Mar 20127:00 amRNSQuarterly Trading Statement
1st Mar 20129:47 amRNSTotal Voting Rights
24th Feb 20129:09 amRNSHolding(s) in Company
22nd Feb 20127:30 amRNSCompany Secretary Change
14th Feb 20122:18 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20124:45 pmRNSInterim Management Statement
2nd Feb 20124:40 pmRNSSecretary Change
2nd Feb 20124:35 pmRNSResult of AGM
2nd Feb 20124:27 pmRNSDirectorate Change
1st Feb 20129:21 amRNSIssue of Equity
30th Jan 201211:24 amRNSAnnual Financial Report
12th Jan 20124:46 pmRNSAnnual Information Update
11th Jan 20123:32 pmRNSScrip dividend reference price
5th Jan 201210:56 amRNSQuarterly Disclosure
16th Dec 201111:15 amRNSDoc re. Annual Report & Circular
12th Dec 201110:26 amRNSDirector/PDMR Shareholding
7th Dec 20113:42 pmRNSDirector/PDMR Shareholding
5th Dec 20114:19 pmRNSDirector/PDMR Shareholding
5th Dec 20112:20 pmRNSDirector/PDMR Shareholding
5th Dec 20117:00 amRNSPreliminary Results
29th Nov 20113:55 pmRNSHolding(s) in Company
11th Oct 201110:22 amRNSDirector Declaration
5th Oct 20117:00 amRNSManagement Incentive Scheme Arrangements
4th Oct 20114:17 pmRNSQuarterly Disclosure
21st Sep 20117:00 amRNSQuarterly Trading Statement
11th Aug 20117:00 amRNSInterim Management Statement
20th Jul 201110:48 amRNSHolding(s) in Company
4th Jul 20111:08 pmRNSQuarterly Disclosure
15th Jun 201110:31 amRNSDirector/PDMR Shareholding
14th Jun 20113:46 pmRNSDirector/PDMR Shareholding
2nd Jun 20119:26 amRNSReplacement - Half Yearly Report
27th May 20117:00 amRNSHalf Yearly Report
4th Apr 20112:57 pmRNSQuarterly Disclosure
1st Apr 20117:00 amRNSDirectorate Change
21st Mar 20113:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.